Effects of Diabetogenic Agent Streptozotocin on Hematological Parameters of Wistar Albino Rats “An Experimental Study”

Main Article Content

Akhtar Ali
Shehla Shaheen
Zahida Memon
Faiza Agha
Moazzam Ali Shahid
Nisha Zahid


Background: Diabetes mellitus has remained the major concern for medical sciences researches due to its deleterious effects on general, physical and mental health of patients. To understand the pathophysiology and to explore better treatment options for such kind of metabolic disorders it is necessary to generate the experimental animal models. To create diabetic animal models, streptozotocin has shown predominance in selectivity as a diabetogenic agent. While studying effects of any intervention in the diabetic animal models, being a cytotoxic drug streptozotocin may affect the study results by inhibiting highly replicating cells especially hematopoietic cells.

Aims: The aim of study was to analyze the effects of streptozotocin on various cellular components of blood such as RBCs, WBCs (Lymphocytes, Neutrophils, Eosinophils), Hb%, HCT and Platelets, at baseline, 5th day and 15th day without any intervention.

Study Design: Animal based Experimental study.

Place and duration of Study: The study was conducted at animal house of faculty of Pharmacy Ziauddin University Karachi, while laboratory work was performed at MDRL-1 Ziauddin University.

Methodology: In Group A normal saline and in group B and C 60 mg / kg streptozotocin diluted in normal saline was administered intraperitoneally. After the confirmation of induction of Diabetes in rats, on fifth day blood samples were drawn from Group A and B and were analyzed. While blood samples from group C were drawn on fifteenth day.

Results: Analysis of various hematological parameters on 5th day revealed that there was a decrease in the levels of Hb, HCT, RBCs and WBCs with an increase in platelet count in group B in comparison to group A (control). On the other hand, in Group C (15th day), blood cell counts (Hb, HCT, RBCs, WBCs, Lymphocytes, Neutrophils and platelets) seemed to recover from streptozotocin induced decline that was observed in group B, however did not reach the baselines as in group A(control).

Conclusion: It is concluded that change in hematological parameters of rats after administration of streptozotocin is reversible. The blood parameters may recover near to base line values without any intervention within two weeks.

Streptozotocin, animal model, hematological parameters.

Article Details

How to Cite
Ali, A., Shaheen, S., Memon, Z., Agha, F., Shahid, M. A., & Zahid, N. (2019). Effects of Diabetogenic Agent Streptozotocin on Hematological Parameters of Wistar Albino Rats “An Experimental Study”. Journal of Advances in Medicine and Medical Research, 30(5), 1-8. https://doi.org/10.9734/jammr/2019/v30i530194
Original Research Article


Federiuk IF, Casey HM, Quinn MJ, Wood MD, Ward KWJCm. Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: Route of administration, pitfalls, and insulin treatment. J Comparative Medicine. 2004;54(3):252-7.

Thatte UJIjop. Still in search of a herbal medicine. Indian Journal of Pharmacology. 2009;41(1):1.

Srinivasan K, Ramarao PJIJoMR. Animal model in type 2 diabetes research: An overview. Indian Journal of Medical Research. 2007;125(3):451.

Holemans K, Aerts L, Van Assche FAJJotSfGI. Fetal growth restriction and consequences for the offspring in animal models. Journal of the Society for Gynecologic Investigation. 2003;10(7):392-9.

Szkudelski TJPr. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. J Physiological Research. 2001;50(6):537-46.

Lenzen SJD. The mechanisms of alloxan-and streptozotocin-induced diabetes. J Diabetologia. 2008;51(2):216-26.

Ito M, Kondo Y, Nakatani A, Naruse AJB, Bulletin P. New model of progressive non-insulin-dependent diabetes mellitus in mice induced by streptozotocin. J Biological Pharmaceutical Bulletin. 1999;22(9):988-9.

Tay YC, Wang Y, Kairaitis L, Rangan GK, Zhang C, Harris DCJKi. Can murine diabetic nephropathy be separated from superimposed acute renal failure? 2005; 68(1):391-8.

Akbarzadeh A, Norouzian D, Mehrabi M, Jamshidi S, Farhangi A, Verdi AA, et al. Induction of diabetes by streptozotocin in rats. Indian Journal of Clinical Biochemistry. 2007;22(2):60-4.

Etuk EJABJA. Animals models for studying diabetes mellitus. J Agric Biol JN Am. 2010;1(2):130-4.

Balamurugan A, Gu Y, Miyamoto M, Wang W, Inoue K, Tabata YJP. Streptozotocin (STZ) is commonly used to induce diabetes in animal models. J Pancreas. 2003;26:102-3.

Steiner H, Oelz O, Zahnd G, Froesch EJD. Studies on islet cell regeneration, hyper-plasia and intrainsular cellular inter-relations in long lasting streptozotocin diabetes in rats. 1970;6(6):558-64.

Yamagami T, Miwa A, Takasawa S, Yamamoto H, Okamoto HJCr. Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly (adenosine diphosphate ribose) synthetase inhibitors. 1985;45(4):1845-9.

Iwase M, Nunoi K, Wakisaka M, Kikuchi M, Maki Y, Sadoshima S, et al. Spontaneous recovery from non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin treatment in spontaneously hypertensive rats. 1991;40(1):10-4.

Kazumi T, Yoshino G, Fujii S, Baba SJCr. Tumorigenic action of streptozotocin on the pancreas and kidney in male Wistar rats. 1978;38(7):2144-7.

Huber JD, VanGilder RL, Houser KAJAJoPH, Physiology C. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. American Journal of Physiology-Heart Circulatory Physiology; 2006.

Olbricht CJ, Geissinger B, Gutjahr EJKi. Renal hypertrophy in streptozotocin diabetic rats: Role of proteolytic lysosomal enzymes. 1992;41(4):966-72.

Crouch R, Kimsey G, Priest D, Sarda A, Buse MJD. Effect of streptozotocin on erythrocyte and retinal superoxide dismutase. 1978;15(1):53-7.

Bolzán AD, Bianchi MSJMRRiMR. Geno-toxicity of streptozotocin. 2002;512(2-3): 121-34.

Jiao Y, Wang X, Jiang X, Kong F, Wang S, Yan CJJoe. Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet-and streptozotocin-induced type 2 diabetes in rats. Journal of Ethnopharmacology. 2017;199:119-27.

Singh M, Shin S. Changes in erythrocyte aggregation and deformability in diabetes mellitus: A brief review; 2009.

Onderoglu S, Sozer S, Erbil KM, Ortac R, Lermioglu FJJoP. Pharmacology. The evaluation of long‐term effects of cinnamon bark and olive leaf on toxicity induced by streptozotocin administration to rats. 1999; 51(11):1305-12.

Oyedemi S, Adewusi E, Aiyegoro O, Akinpelu DJAPjotb. Antidiabetic and haematological effect of aqueous extract of stem bark of Afzelia africana (Smith) on streptozotocin–induced diabetic Wistar rats. 2011;1(5):353-8.

Sellamuthu PS, Arulselvan P, Fakurazi S, Kandasamy MJPJPS. Beneficial effects of mangiferin isolated from Salacia chinensis on biochemical and hematological parameters in rats with streptozotocin-induced diabetes. 2014;27(1):161-7.

Verma N, Amresh G, Sahu P, Mishra N, Singh AP, Rao CVJAPjotm. Antihyper-glycemic activity, antihyperlipedemic activity, haematological effects and histo-pathological analysis of Sapindus mukorossi Gaerten fruits in streptozotocin induced diabetic rats. 2012; 5(7):518-22.

Çolak S, Geyikoğlu F, Aslan A, Deniz GYJT, health i. Effects of lichen extracts on haematological parameters of rats with experimental insulin-dependent diabetes mellitus. 2014;30(10):878-87.

Cho YI, Mooney MP, Cho DJJJods, technology. Hemorheological disorders in diabetes mellitus. 2008;2(6):1130-8.

Yeom E, Byeon H, Lee SJJSr. Effect of diabetic duration on hemorheological properties and platelet aggregation in streptozotocin-induced diabetic rats. 2016; 6:21913.

Council NR. Guide for the care and use of laboratory animals: National Academies Press; 2010.